发明名称 TARGETED POLYMERIC INFLAMMATION-RESOLVING NANOPARTICLES
摘要 <p>Sub- 100 micron multimodal nanoparticles have four main components: 1) a target element (peptides, lipids, antibodies, small molecules, etc.) that can selectively bind to cells, tissues, or organs of the body; 2) a diagnostic agent such as a fiuorophore or NMR contrast agent that allows visualization of nanoparticles at the site of delivery and/or a therapeutic or prophylactic agent; 3) an outside "stealth" layer that allows the particles to evade recognition by immune system components and increase particle circulation half-life; and 4) a biodegradable polymeric material, forming an inner core which can carry therapeutics and release the payloads at a sustained rate after systemic, intraperitoneal, or mucosal administration. These particles possess excellent stability, high loading efficiency, multiple agent encapsulation, targeting and imaging. They are targeted to sites of, or associated with, inflammation caused by a disease, disorder; trauma, chemotherapy or radiation.</p>
申请公布号 WO2014145749(A1) 申请公布日期 2014.09.18
申请号 WO2014US30563 申请日期 2014.03.17
申请人 THE BRIGHAM AND WOMEN'S HOSPITAL, INC.;MASSACHUSETTS INSTITUTE OF TECHNOLOGY;THE TRUSTEES OF COLUMBIA UNIVERSITY 发明人 FAROKHAZAD, OMID, C.;ZHANG, XUEQING;XU, XIAOYANG;KAMALY, NAZILA;MA, MINGMING;VALENCIA, PEDRO, M.;LANGER, ROBERT, S.;TABAS, IRA;FREDMAN, GABRIELLE, BETH
分类号 A61K9/14;A61P29/00;A61P37/00 主分类号 A61K9/14
代理机构 代理人
主权项
地址